Editorial

José Pacheco Romero

doi:10.31403/rpgo.v58i39

Autores/as

José Pacheco Romero Profesor Principal, Departamento de Obstetricia y Ginecología Facultad de Medicina de San Fernando, Universidad Nacional Mayor de San Marcos

DOI:

https://doi.org/10.31403/rpgo.v58i39

Resumen

El presente número de fin de año 2012 de la Revista Peruana de Ginecología y Obstetricia les trae novedades en investigación en la especialidad, en trabajos presentados en el XIX Congreso Peruano de Ginecología y Obstetricia, que dan una pauta del futuro promisor que le toca a nuestra especialidad. Así mismo, ofrecemos otra novedad, en un interesante y polémico Simposio sobre Anemia, en donde en dos artículos científicos, los Drs. Milman, de Dinamarca, y Breymann, de Suiza, nos presentan excelentes revisiones completas sobre el tema en inglés y español.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Corbex M, Burton R, Sancho-Garnier H. Breast cancer early detection methods por low and middle income countries, a review of the evidence. Breast. 2012;21(4):428- 34.

American Medical Association (AMA) 2012 Annual Meeting. Presentado el 21 de junio de 2012. Medscape Ob/Gyn & Women’s Health. Disponible en http://www.medscape.com/viewarticle/766289. Obtenido el 15 de noviembre de 2012.

U.S. Preventive Services Task Force. Screening for breast cáncer. November 2009. Disponible en: http://www.uspreventiveservicestaskforce. org/uspstf/uspsbrca.htm. Obtenido el 15 de noviembre de 2012.

Naasan M, Waterstone J, Johnston MM, Nolan A, Egan D, Shamoun O, Thompson W, Roopnarinesingh R, Wingfield M, Harrison RF, Mocanu E. Assisted reproductive technology treatment outcomes. Ir Med J. 2012 May;105(5):136-9.

Cohen J, Alikani M, Bisignano A. Past performance of assisted reproduction technologies as a model to predict future progress: a proposed addendum to Moore's law. Reprod Biomed Online. 2012 Sep 12. doi:pii: S1472-6483(12)00529-9.

Pinborg A, Wennerholm UB, Romundstad LB, Loft A, Aittomaki K, Söderström-Anttila V, Nygren KG, Hazekamp J, Bergh C. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update. 2012 Nov 14. [Epub ahead of print].

Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev. 2012 Jul 11;7:CD002118.

Nogueira D, Sadeu JC, Montagut J. In vitro oocyte maturation: current status. Semin Reprod Med. 2012 Jun;30(3):199-213.

Clinical application of in vitro maturation of human immature oocytes for infertile women with polycystic ovary syndrome]. Zhonghua Fu Chan Ke Za Zhi. 2012 Jan;47(1):14-8.

Roesner S, Von Wolff M, Eberhardt I, Beuter-Winkler P, Toth B, Strowitzki T. In vitro maturation: a five-year experience. Acta Obstet Gynecol Scand. 2012 Jan;91(1):22-7.

Xu YP, Xiang HF, Zou WW, Li ZL, Zhang ZG, Zhou P, Cao YX. [Clinical application of in vitro maturation of human immature oocytes for infertile women with polycystic ovary syndrome]. Zhonghua Fu Chan Ke Za Zhi. 2012;47(1):14-8.

Medscape Reference. Drugs, Diseases & Procedures. Cystic hygroma. Disponible en: http://emedicine.medscape. com/article/994055-overview. Obtenido el 12 de diciembre de 2012.

Emory University School of Medicine. Department of Human Genetics. Cystic higroma. FS_021.2_2008. Disponible en: http://genetics.emory.edu/pdf/Emory_Human_Genetics_Cystic_Hygroma.PDF. Obtenido el 12 de diciembre de 2012.

Michailidis GD, Spencer K, Economides DL: The use of nuchal translucency measurement and second trimester biochemical markers in screening for Down’s Syndrome. Brit J Obstet Gynaecol. 2001;108:1047-52. 15. Berger A. What is fetal nuchal translucency? BMJ. 1999;318(7176):81.

Haak MC, van Vugt JMG. Pathophysiology of increased nuchal translucency. A review of the literature. Hum Reprod Update. 2003;9(2):175-84.

von Kaisenberg CS, Wilting J, Dörk T, Nicolaides KH, Meinhold-Heerlein I, Hillemanns P, Brand-Saberi B. Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls. Mol Hum Reprod. 2010;16(10):778-89.

Chelli D, Gaddour I, Najar I, Boudaya F, Zouaoui B, Sfar E, Chaabouni H, Chelli H, Mohamed C. [First trimester ultrasound: an early screening tool for fetal structural and chromosomal abnormalities]. Tunis Med. 2009;87(12):857-62.

Beke A, Joó JG, Csaba A, Lázár L, Bán Z, Papp C, Tóth-Pál E, Papp Z. Incidence of chromosomal abnormalities in the presence of fetal subcutaneous oedema, such as nuchal oedema, cystic hygroma and non-immune hydrops. Fetal Diagn Ther. 2009;25(1):83-92.

Bekker MN, van den Akker NM, de Mooij YM, Bartelings MM, van Vugt JM, Gittenberger-de Groot AC. Jugular lymphatic maldevelopment in Turner syndrome and trisomy 21: different anomalies leading to nuchal edema. Reprod Sci. 2008;15(3):295-304.

Kharrat R, Yamamoto M, Roume J, Couderc S, Vialard F, Hillion Y, Ville Y. Karyotype and outcome of fetuses diagnosed with cystic hygroma in the first trimester in relation to nuchal translucency thickness. Prenat Diagn. 2006;26(4):369-72.

Sananes N, Guigue V, Kohler M, Bouffet N, Cancellier M, Hornecker F, Hunsinger MC, Kohler A, Mager C, Neumann M, Schmerber E, Tanghe M, Nisand I, Favre R. Nuchal translucency and cystic hygroma colli in screening for fetal major congenital heart defects in a series of 12,910 euploid pregnancies. Ultrasound Obstet Gynecol. 2010;35(3):273-9.

Ducarme G, Graesslin O, Alanio E, Bige V, Gaillard D, Gabriel R. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome]. Gynecol Obstet Fertil. 2005;33(10):750-4.

Geller SE, Rosenberg D, Cox S, Brown M, Simonson L, Kilpatrick S. A scoring system identified near-miss maternal morbidity during pregnancy. J Clin Epidemiol. 2004 Jul;57(7):716-20.

Tunçalp O, Hindin MJ, Souza JP, Chou D, Say L. The prevalence of maternal near miss: a systematic review. BJOG. 2012;119(6):653-61.

Souza JP, Cecatti JG, Haddad SM, Parpinelli MA, Costa ML, Katz L, Say L; Brazilian Network for Surveillance of Severe Maternal Morbidity Group; Brazilian Network for Surveillance of Severe Maternal Morbidity. The WHO maternal near-miss approach and the maternal severity index model (MSI): tools for assessing the management of severe maternal morbidity. PLoS One. 2012;7(8):e44129.

Lotufo FA, Parpinelli MA, Haddad SM, Surita FG, Cecatti JG. Applying the new concept of maternal near-miss in an intensive care unit. Clinics (Sao Paulo). 2012;67(3):225-30.

Reime B, Janssen PA, Farris L, Borde T, Hellmers C, Myezwa H, Wenzlaff P. Maternal near-miss among women with a migrant background in Germany. Acta Obstet Gynecol Scand. 2012;91(7):824-9.

Pacagnella RC, Cecatti JG, Osis MJ, Souza JP. The role of delays in severe maternal morbidity and mortality: expanding the conceptual framework. Reprod Health Matters. 2012;20(39):155-63.

Brown H, Small M. The role of the maternal-fetal medicine subspecialist in review and prevention of maternal deaths. Semin Perinatol. 2012 Feb;36(1):27-30.